Year: 2018
Type: dissertation
Abstract: Cancer is a worldwide problem that affects many people every day and among women, \nbreast cancer is by far the most commonly diagnosed cancer. It has been known for quite \nsome time now that inherited germline mutation in the tumour suppressor genes BRCA1 \nand BRCA2 can increase the likelihood of cancer progression dramatically. However, \nthese mutations can only explain a fraction of all breast cancer diagnosed. Therefore, \nscientists have been searching for mutations in other genes, both germline and somatic, \nthat might contribute to cancer progression, with the purpose of getting a better \nunderstanding of their role and use that information for personalized treatments. One factor \nthat potentially has a clinical role is the DNA methylation of promoter regions of genes \nthat participate in the DNA damage response leading to their suppression. Many studies \nhave shown that double-stranded-DNA-breaks lead to genomic instability which can lead \nto cancer. In this study, the main purpose was to examine the promoter methylation of \nthree different genes, NABP-1, TP53I3 and RAD51C which all participate in the DNA \ndamage response using different cell lines. With this in mind my objective was to evaluate \nwhether any of these cell lines, OVCAR-8, MCF-7, MCF-10A and T47D could be used as \na model cell line for further studies of the subject.
Source: Skemman
Author: Katrín Eir Smáradóttir 1994
Institution: University of Iceland
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7051978148
